Alternatively, if PD-1 and TIGIT expressed on chronically activated Treg present within the tumor micro-environment both contribute to their strong suppressive capacity, PD-1 blockade may synergize with TIGIT-blockade in reducing local immune-suppression exerted by tumor-infiltrating Treg functions. The gene discussed is TIGIT; the disease is neoplasm.